KIR2DL4 mediates NK-cell activation via inducing proliferation and survival pathways such as NF-κB and AKT, which may contribute to NKTCL pathogenesis [38]. The gene discussed is AKT1; the disease is extranodal nasal NK/T cell lymphoma.